Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Infection problems for the 1990's--do we have an answer?

H C Neu1

  • 1College of Physicians & Surgeons, Columbia University, New York, New York 10032.

Scandinavian Journal of Infectious Diseases. Supplementum
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Postantibiotic effect of ceftibuten on respiratory pathogens.

The Pediatric infectious disease journal·1995
Same author

Ceftibuten: minimal inhibitory concentrations, postantibiotic effect and beta-lactamase stability--a rationale for dosing programs.

The Pediatric infectious disease journal·1995
Same author

Emerging trends in antimicrobial resistance in surgical infections. A review.

The European journal of surgery. Supplement. : = Acta chirurgica. Supplement·1994
Same author

Synergy and antagonism of fluoroquinolones with other classes of antimicrobial agents.

Drugs·1993
Same author

Gemfibrozil enhances the listeriacidal effects of fluoroquinolone antibiotics in J774 macrophages.

The Journal of experimental medicine·1992
Same author

In vitro activity of CP-74,667. A new fluoroquinolone compared with other quinolones.

Diagnostic microbiology and infectious disease·1992
Same journal

Annual disease burden due to human papillomavirus 16 and 18 infections in Finland.

Scandinavian journal of infectious diseases. Supplementum·2009
Same journal

Annual disease burden due to human papillomavirus (HPV) 6 and 11 infections in Finland.

Scandinavian journal of infectious diseases. Supplementum·2009
Same journal

Supreme Court decision on genotypic tests for antiretroviral drugs resistance: Joint Criminal Divisions.

Scandinavian journal of infectious diseases. Supplementum·2004
Same journal

Brief summary of the legal proceeding.

Scandinavian journal of infectious diseases. Supplementum·2004
Same journal

Too early or too late: a never-ending dilemma with new technologies.

Scandinavian journal of infectious diseases. Supplementum·2004
Same journal

Genotypic resistance tests for the management of postexposure prophylaxis.

Scandinavian journal of infectious diseases. Supplementum·2004
See all related articles

Antimicrobial resistance is increasing, with Gram-positive bacteria and fungi becoming more prevalent. Better prescribing practices can help manage resistant organisms like MRSA and vancomycin-resistant enterococci.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Hospital Epidemiology

Background:

  • Hospital-acquired infections are evolving, with a rise in Gram-positive bacteria and fungi alongside Gram-negative pathogens.
  • Emerging resistant organisms include methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), and multidrug-resistant Gram-negative bacteria.
  • Intensive Care Unit (ICU) patients often carry a diverse range of resistant bacteria, posing a risk of transmission throughout the hospital.

Purpose of the Study:

  • To investigate the impact of antimicrobial prescribing practices on the emergence and spread of resistant hospital-acquired pathogens.
  • To evaluate strategies for mitigating antimicrobial resistance, focusing on Gram-positive bacteria, fungi, and multidrug-resistant Gram-negative organisms.
  • To assess the role of judicious antibiotic use in intensive care settings in preserving antibiotic efficacy for other patient populations.

Related Experiment Videos

Main Methods:

  • Analysis of trends in hospital-acquired infections and pathogen resistance patterns.
  • Review of antimicrobial prescribing practices and their correlation with resistance selection.
  • Case study analysis of specific resistant organisms and their transmission dynamics.

Main Results:

  • Certain antimicrobial agents can inadvertently select for resistant strains, such as fluoroquinolones selecting for MRSA.
  • Restricting oral vancomycin use can reduce selective pressure for vancomycin-resistant Enterococcus faecium and limit glycopeptide resistance transmission.
  • Judicious antibiotic use in ICUs is crucial for conserving effective treatments, as ICU patients frequently harbor and disseminate multiple resistant organisms.

Conclusions:

  • Antimicrobial stewardship is essential to combat the growing threat of resistant hospital-acquired infections.
  • Targeted interventions, like vancomycin restriction, can significantly impact the prevalence of specific resistant pathogens.
  • Optimizing antibiotic use in critical care settings is vital for maintaining treatment options across the hospital.